Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia

NCT02825212 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
Cryoglobulinemia

Interventions

DRUG: Harvoni
DRUG: Epclusa

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]